BIODESIX INC (54) | Uncategorized (13)

Recent Contracts

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2021)
Letter from Bio-Rad Laboratories, Inc. dated August 7, 2020 (Filed With SEC on October 21, 2020)
Letter from Bio-Rad Laboratories, Inc. dated August 14, 2020 (Filed With SEC on October 21, 2020)
Form of Option Agreement under the Biodesix, Inc. Bonus-To-Options Program (Filed With SEC on October 9, 2020)
Biodesix, Inc., First Amended Bonus-to-Options Program, adopted by the Board of Directors on October 15, 2010 (Filed With SEC on October 2, 2020)
Biodesix, Inc., Second Amended Bonus-to-Options Program, adopted by the Board of Directors on June 21, 2011 (Filed With SEC on October 2, 2020)
Biodesix, Inc., Third Amended Bonus-to-Options Program, adopted by the Board of Directors on December 31, 2015 (Filed With SEC on October 2, 2020)
Contingent Value Rights Agreement between Biodesix, Inc. and Holders on Schedule A mentioned within, dated February 22, 2016 (Filed With SEC on October 2, 2020)
Contract Agreement between Biodesix, Inc. and the Colorado Department of Public Health and Environment, dated September 11, 2020 (Filed With SEC on October 2, 2020)
Material Transfer Agreement by and between Biodesix, Inc. and Bio-Rad Laboratories, Inc., dated March 23, 2020 (Filed With SEC on October 2, 2020)
First Amendment to Material Transfer Agreement by and between Biodesix, Inc. and Bio-Rad Laboratories, Inc. dated April 3, 2020 (Filed With SEC on October 2, 2020)
Material Transfer Agreement by and between Biodesix, Inc. and Bio-Rad Laboratories, Inc., dated April 17, 2020 (Filed With SEC on October 2, 2020)
Price Agreement by and between Biodesix, Inc. and Bio-Rad Laboratories, Inc., dated May 12, 2020 (Filed With SEC on October 2, 2020)